Description
Inclusion Criteria:
- * Patients with the following are eligible:
- * Malignant or non-invasive, neoplastic lesions of the stomach confirmed by histopathology or cytopathology in a CLIA-certified laboratory
- OR
- --Suspicious lesions not yet confirmed, but considered likely to be related to the stomach pending further evaluation
- OR
- * Confirmed, deleterious germline mutation (including but not limited to HDGC, GAPPS) known to predispose to gastric tumors;
- * Confirmed or suspicious heritable gastric malignancy disorder;
- * Clinically suspicious personal or family medical history of gastric cancer or gastric cancer syndrome that warrants genetics evaluation.
- * Patients must have an ECOG performance score of 0-2.
- * Age greater than or equal to 2 years. Note: Patients greater than or equal to 2 and less than or equal to 18 years of age may only participate in research sample collection if the tissue acquisition is performed during a clinically indicated surgical procedure, and the sampling of tissue, blood and urine does not add risk to the clinically indicated procedures.
- * The patient is a candidate for the clinically indicated medical evaluations that are being offered
- * Ability of subject, their parents/guardians or legally authorized representative (LAR) to understand and must be willing to sign a written informed consent document.
Exclusion Criteria:
- Candidates who do not meet the inclusion criteria.
Ages Eligible for Study:
2 Years to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No